FDA Adds OTC Eye Ointment to List of Possibly Contaminated Products
Earlier this month, Global Pharma Healthcare had announced a nationwide recall of its artificial tear lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma.
Diagnosis & Disease Information
At-Home Combination Test for COVID-19, Flu Gets Emergency Use Authorization
The Lucira COVID-19 & Flu Home test is a single-use, nucleic acid amplification test intended for individuals with signs and symptoms consistent with a respiratory tract infection.
FDA to Review Letermovir for CMV Disease Prevention in Kidney Transplant Recipients
Letermovir is currently marketed under the brand name Prevymis for prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic HSCT.
Shingles: Raising Awareness and Promoting Vaccination
Despite the availability of a highly effective shingles vaccine and almost universal risk among those born before 1980, Americans are not getting vaccinated.
Artificial Tears Recalled Due to Possible Infection Risk
The recalled lots of Artificial Tears Lubricant Eye Drops, 10mg in 1mL, ½ fl oz (15mL) bottles were distributed nationwide by EzriCare, LLC and Delsam Pharma.
Lack of Efficacy Ends Trial Evaluating Janssen’s HIV Vaccine Candidate
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
COVID-19 Update: Long COVID Rehab, Post-mRNA Vaccine Myocarditis, and Home Test-to-Treat Program
Recent COVID-19 updates include a successful pacing program for people with long COVID symptoms, a blood marker for post-vaccine myocarditis, and the first home test-to-treat program.
Discontinuation of Several HIV Medications Reported to FDA
The HIV medications are all manufactured by ViiV Healthcare, a GlaxoSmithKline.
Olorofim Under Review for Invasive Fungal Infections
Olorofim is part of a new class of antifungal agents called orotomides.
Hepatitis C Guideline Updated for Chronic Kidney Disease Population
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...